publication venue for
- Long-Term Quality of Life Response Observed in the Baroreflex Activation Therapy for HeartFailure Trial 2024
- Broad Quality of Life Effects forSpecificMedications: Feeling Better and Doing More? 2023
- Hemodynamic-Guided HeartFailure Management in Patients With Either PriorHF Hospitalization or Elevated Natriuretic Peptides. 11:691-698. 2023
- Hemodynamically-Guided Management of HeartFailure Across the EjectionFraction Spectrum: The GUIDE-HF Trial. 10:931-944. 2022
- Response by Sex in Patient-Centered Outcomes With Baroreflex Activation Therapy in Systolic HeartFailure. 9:430-438. 2021